New Trends in Urologic Oncology: Surgical Treatments, Robotics, Biomarkers, Diagnostic Tools, and Innovative Therapies
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Clinical Research of Cancer".
Deadline for manuscript submissions: 31 July 2026 | Viewed by 42
Special Issue Editors
Interests: prostate cancer; BPH; urothelial cancer
Interests: bladder cancer; urothelial carcinoma; non-muscle-invasive bladder cancer
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Urologic oncology is undergoing rapid development, with significant progress across surgical, diagnostic, and therapeutic domains. This Special Issue, “New Trends in Urologic Oncology: Surgical Treatments, Robotics, Biomarkers, Diagnostic Tools, and Innovative Therapies”, will provide an overview of the most recent advances shaping the management of genitourinary malignancies. Particular attention will be given to the evolution of minimally invasive and robotic-assisted techniques, the refinement of surgical outcomes, and the integration of novel systemic and targeted treatment strategies.
In parallel, the identification and clinical implementation of biomarkers, together with advances in molecular and imaging-based diagnostics, are enabling earlier detection, more precise risk stratification, and individualized therapeutic approaches. These developments are progressively moving the field toward a model of precision oncology, in which treatment decisions are informed by both technological innovation and molecular characterization.
We welcome contributions in the form of original research articles, reviews, and clinical studies that reflect these advances and will help in defining new standards of care.
Dr. Alessandro Uleri
Dr. Roberto Contieri
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- prostate cancer
- renal cancer
- bladder cancer
- UTUC
- testicular cancer
- penile cancer
- biomarkers
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
